$885.32
-8.07-0.9%
At close: Aug 31, 5:00 PM EST
$885.32
N/A
After Hours: 4:05 PM EST
McKesson Corp
MCKNYSE
Dividend: The dividend Ex-Date is today
M&A: Precision Medicine Group, LLC announced it will be acquired by McKesson (MCK) on Tuesday, August 25, 2026 for $2.3B
McKesson Earnings & Forecasts
McKesson (MCK) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
McKesson Guidance
McKesson (MCK) last issued guidance on August 5, 2026 for fiscal year 2027. The company guided earnings per share in the range of $44.2 - $45, compared to a consensus EPS estimate of $44.27. McKesson also guided revenue in the range of $423.6B - $439.74B for the period.
Compared to prior guidance, McKesson maintained its EPS outlook from a previous range of $43.8 - $44.6.
McKesson has issued 21 guidance updates between November 1, 2022 and August 5, 2026. During this period, the company raised its outlook 11 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $9.62 | $11.57 | $9.29 | $9.00 |
| Actual | $9.93 | $11.69 | $9.34 | $9.86 |
| Surprise | +3.22% | +1.04% | +0.54% | +9.56% |
| Revenue | ||||
| Estimate | $104.08B | $101.49B | $105.81B | $104.34B |
| Actual | $105.38B | $96.30B | $106.16B | $103.15B |
| Surprise | +1.25% | -5.12% | +0.33% | -1.14% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $10.72 | $11.10 | $12.66 | $10.67 |
| Revenue | ||||
| Consensus | $109.97B | $113.19B | — | — |
